ENTX Entera Bio Ltd

Price (delayed)

$2.87

Market cap

$496.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$478.91M

?
Relative Growth: Rel. Growth: 1
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

Entera is a leader in the development of orally delivered large molecule therapeutics for use in areas with significant unmet medical need where adoption of injectable therapies is limited due ...

Highlights
The debt has surged by 109% year-on-year but it has declined by 5% since the previous quarter
ENTX's quick ratio is up by 16% since the previous quarter but it is down by 14% year-on-year
Entera Bio's revenue has plunged by 100% YoY
The net income has dropped by 61% year-on-year and by 38% since the previous quarter

Key stats

What are the main financial stats of ENTX

ENTX stock price

How has the Entera Bio stock price performed over time
Intraday
2.5%
1 week
1.77%
1 month
75%
1 year
47.94%
YTD
47.94%
QTD
62.15%

Financial performance

How have Entera Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.4M
Net income
-$17.03M
Gross margin
N/A
Net margin
N/A
Entera Bio's revenue has plunged by 100% YoY
The net income has dropped by 61% year-on-year and by 38% since the previous quarter
ENTX's operating income is down by 36% year-on-year and by 15% since the previous quarter

Price vs fundamentals

How does ENTX's price correlate with its fundamentals

Growth

What is Entera Bio's growth rate over time

Valuation

What is Entera Bio stock price valuation
P/E
N/A
P/B
19.44
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 35% year-on-year and by 30% since the previous quarter
ENTX's P/B is 166% above its last 4 quarters average of 7.3
The equity has dropped by 58% year-on-year and by 32% since the previous quarter
Entera Bio's revenue has plunged by 100% YoY

Efficiency

How efficient is Entera Bio business performance
ENTX's return on equity has dropped by 78% year-on-year and by 67% since the previous quarter
Entera Bio's ROA has decreased by 42% YoY and by 38% from the previous quarter

Dividends

What is ENTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENTX.

Financial health

How did Entera Bio financials performed over time
Entera Bio's total assets is 59% more than its total liabilities
Entera Bio's total assets has increased by 48% from the previous quarter
ENTX's quick ratio is up by 16% since the previous quarter but it is down by 14% year-on-year
The debt is 94% smaller than the equity
The debt has surged by 109% year-on-year but it has declined by 5% since the previous quarter
The equity has dropped by 58% year-on-year and by 32% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.